Friday April 10, 2020

New stroke drugs linked to 31 deaths

Concerns about the safety of Pradaxa since its approval for use in Europe and the United States.

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
27th July, 2014
Blood thinners are used to reduce the risk of stroke and blood clots in patients. Picture: Getty

Twelve deaths associated with the use of controversial blood thinners Xarelto and Pradaxa have been reported to the medicines regulator during the first six months of this year.

They bring the total number of deaths reported in association with these new drugs to 31 since the start of 2012.

All blood thinners carry the risk of dangerous bleeding, but there have been persistent and lingering concerns about the safety of Pradaxa in particular since its approval in...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 3 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago